APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Yellow Nail Syndrome Treatment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Yellow Nail Syndrome Treatment Market Outlook and Growth Opportunities 2026

Report ID 174048380431 December 2025203 pages

Choose your research edition.

Industry ResearchYellow Nail Syndrome Treatment Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Yellow Nail Syndrome Treatment Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Yellow Nail Syndrome Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Yellow Nail Syndrome Treatment Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Yellow Nail Syndrome Treatment Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Yellow Nail Syndrome Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Yellow Nail Syndrome Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Yellow Nail Syndrome Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Yellow Nail Syndrome Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Yellow Nail Syndrome Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Yellow Nail Syndrome Treatment market include Abbott, Sanofi, Johnson & Johnson, Novartis, Merck, Merck, Mylan, Roche and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Yellow Nail Syndrome Treatment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Yellow Nail Syndrome Treatment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Yellow Nail Syndrome Treatment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Yellow Nail Syndrome Treatment market.

Yellow Nail Syndrome Treatment Segment by Company

Abbott

Sanofi

Johnson & Johnson

Novartis

Merck

Merck

Mylan

Roche

Pfizer

GlaxoSmithKline

Bayer

AstraZeneca

Teva Pharmaceutical

Sun Pharmaceutical

Sumitomo Corporation

Enzon Pharmaceuticals

Cipla

Allergan

Yellow Nail Syndrome Treatment Segment by Type

Capsule

Cream

Tablet

Injection

Others

Yellow Nail Syndrome Treatment Segment by Application

Hospital

Clinic

Others

Yellow Nail Syndrome Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Yellow Nail Syndrome Treatment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Yellow Nail Syndrome Treatment key companies, revenue, market share, and recent developments.

3. To split the Yellow Nail Syndrome Treatment breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Yellow Nail Syndrome Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Yellow Nail Syndrome Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze Yellow Nail Syndrome Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Yellow Nail Syndrome Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Yellow Nail Syndrome Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Yellow Nail Syndrome Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Yellow Nail Syndrome Treatment industry.

Chapter 3: Detailed analysis of Yellow Nail Syndrome Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Yellow Nail Syndrome Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Yellow Nail Syndrome Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Yellow Nail Syndrome Treatment Industry Trends Table 2. Yellow Nail Syndrome Treatment Industry Drivers Table 3. Yellow Nail Syndrome Treatment Industry Opportunities and Challenges Table 4. Yellow Nail Syndrome Treatment Industry Restraints Table 5. Global Yellow Nail Syndrome Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Yellow Nail Syndrome Treatment Revenue Share by Company (2021-2026) Table 7. Global Yellow Nail Syndrome Treatment Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Yellow Nail Syndrome Treatment Key Company Manufacturing Base & Headquarters Table 9. Global Yellow Nail Syndrome Treatment Company, Product Type & Application Table 10. Global Yellow Nail Syndrome Treatment Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Yellow Nail Syndrome Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Capsule Table 15. Significant Companies of Cream Table 16. Significant Companies of Tablet Table 17. Significant Companies of Injection Table 18. Significant Companies of Others Table 19. Global Yellow Nail Syndrome Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Yellow Nail Syndrome Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Yellow Nail Syndrome Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Yellow Nail Syndrome Treatment Sales Value Share by Type (2021-2026) Table 23. Global Yellow Nail Syndrome Treatment Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Hospital Table 25. Significant Companies of Clinic Table 26. Significant Companies of Others Table 27. Global Yellow Nail Syndrome Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Yellow Nail Syndrome Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Yellow Nail Syndrome Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Yellow Nail Syndrome Treatment Sales Value Share by Application (2021-2026) Table 31. Global Yellow Nail Syndrome Treatment Sales Value Share by Application (2027-2032) Table 32. Global Yellow Nail Syndrome Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Yellow Nail Syndrome Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Yellow Nail Syndrome Treatment Sales Value Share by Region (2021-2026) Table 35. Global Yellow Nail Syndrome Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Yellow Nail Syndrome Treatment Sales Value Share by Region (2027-2032) Table 37. Global Yellow Nail Syndrome Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Yellow Nail Syndrome Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Yellow Nail Syndrome Treatment Sales Value Market Share by Country (2021-2026) Table 40. Global Yellow Nail Syndrome Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Yellow Nail Syndrome Treatment Sales Value Market Share by Country (2027-2032) Table 42. Abbott Company Information Table 43. Abbott Business Overview Table 44. Abbott Yellow Nail Syndrome Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Abbott Yellow Nail Syndrome Treatment Product Portfolio Table 46. Abbott Recent Development Table 47. Sanofi Company Information Table 48. Sanofi Business Overview Table 49. Sanofi Yellow Nail Syndrome Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Sanofi Yellow Nail Syndrome Treatment Product Portfolio Table 51. Sanofi Recent Development Table 52. Johnson & Johnson Company Information Table 53. Johnson & Johnson Business Overview Table 54. Johnson & Johnson Yellow Nail Syndrome Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Johnson & Johnson Yellow Nail Syndrome Treatment Product Portfolio Table 56. Johnson & Johnson Recent Development Table 57. Novartis Company Information Table 58. Novartis Business Overview Table 59. Novartis Yellow Nail Syndrome Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Novartis Yellow Nail Syndrome Treatment Product Portfolio Table 61. Novartis Recent Development Table 62. Merck Company Information Table 63. Merck Business Overview Table 64. Merck Yellow Nail Syndrome Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Merck Yellow Nail Syndrome Treatment Product Portfolio Table 66. Merck Recent Development Table 67. Merck Company Information Table 68. Merck Business Overview Table 69. Merck Yellow Nail Syndrome Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Merck Yellow Nail Syndrome Treatment Product Portfolio Table 71. Merck Recent Development Table 72. Mylan Company Information Table 73. Mylan Business Overview Table 74. Mylan Yellow Nail Syndrome Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Mylan Yellow Nail Syndrome Treatment Product Portfolio Table 76. Mylan Recent Development Table 77. Roche Company Information Table 78. Roche Business Overview Table 79. Roche Yellow Nail Syndrome Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Roche Yellow Nail Syndrome Treatment Product Portfolio Table 81. Roche Recent Development Table 82. Pfizer Company Information Table 83. Pfizer Business Overview Table 84. Pfizer Yellow Nail Syndrome Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Pfizer Yellow Nail Syndrome Treatment Product Portfolio Table 86. Pfizer Recent Development Table 87. GlaxoSmithKline Company Information Table 88. GlaxoSmithKline Business Overview Table 89. GlaxoSmithKline Yellow Nail Syndrome Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. GlaxoSmithKline Yellow Nail Syndrome Treatment Product Portfolio Table 91. GlaxoSmithKline Recent Development Table 92. Bayer Company Information Table 93. Bayer Business Overview Table 94. Bayer Yellow Nail Syndrome Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Bayer Yellow Nail Syndrome Treatment Product Portfolio Table 96. Bayer Recent Development Table 97. AstraZeneca Company Information Table 98. AstraZeneca Business Overview Table 99. AstraZeneca Yellow Nail Syndrome Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. AstraZeneca Yellow Nail Syndrome Treatment Product Portfolio Table 101. AstraZeneca Recent Development Table 102. Teva Pharmaceutical Company Information Table 103. Teva Pharmaceutical Business Overview Table 104. Teva Pharmaceutical Yellow Nail Syndrome Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Teva Pharmaceutical Yellow Nail Syndrome Treatment Product Portfolio Table 106. Teva Pharmaceutical Recent Development Table 107. Sun Pharmaceutical Company Information Table 108. Sun Pharmaceutical Business Overview Table 109. Sun Pharmaceutical Yellow Nail Syndrome Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Sun Pharmaceutical Yellow Nail Syndrome Treatment Product Portfolio Table 111. Sun Pharmaceutical Recent Development Table 112. Sumitomo Corporation Company Information Table 113. Sumitomo Corporation Business Overview Table 114. Sumitomo Corporation Yellow Nail Syndrome Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Sumitomo Corporation Yellow Nail Syndrome Treatment Product Portfolio Table 116. Sumitomo Corporation Recent Development Table 117. Enzon Pharmaceuticals Company Information Table 118. Enzon Pharmaceuticals Business Overview Table 119. Enzon Pharmaceuticals Yellow Nail Syndrome Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Enzon Pharmaceuticals Yellow Nail Syndrome Treatment Product Portfolio Table 121. Enzon Pharmaceuticals Recent Development Table 122. Cipla Company Information Table 123. Cipla Business Overview Table 124. Cipla Yellow Nail Syndrome Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Cipla Yellow Nail Syndrome Treatment Product Portfolio Table 126. Cipla Recent Development Table 127. Allergan Company Information Table 128. Allergan Business Overview Table 129. Allergan Yellow Nail Syndrome Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Allergan Yellow Nail Syndrome Treatment Product Portfolio Table 131. Allergan Recent Development Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Yellow Nail Syndrome Treatment Product Image Figure 2. Global Yellow Nail Syndrome Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Yellow Nail Syndrome Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Capsule Image Figure 8. Cream Image Figure 9. Tablet Image Figure 10. Injection Image Figure 11. Others Image Figure 12. Global Yellow Nail Syndrome Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Yellow Nail Syndrome Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Yellow Nail Syndrome Treatment Sales Value Share by Type (2021-2032) Figure 15. Hospital Image Figure 16. Clinic Image Figure 17. Others Image Figure 18. Global Yellow Nail Syndrome Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Yellow Nail Syndrome Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Yellow Nail Syndrome Treatment Sales Value Share by Application (2021-2032) Figure 21. Global Yellow Nail Syndrome Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Yellow Nail Syndrome Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Yellow Nail Syndrome Treatment Sales Value (2021-2032) & (US$ Million) Figure 24. North America Yellow Nail Syndrome Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Yellow Nail Syndrome Treatment Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Yellow Nail Syndrome Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Yellow Nail Syndrome Treatment Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Yellow Nail Syndrome Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Yellow Nail Syndrome Treatment Sales Value (2021-2032) & (US$ Million) Figure 30. South America Yellow Nail Syndrome Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Yellow Nail Syndrome Treatment Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Yellow Nail Syndrome Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Cream
  • Tablet
  • Injection
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Abbott
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck
  • Merck
  • Mylan
  • Roche
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • AstraZeneca
  • Teva Pharmaceutical
  • Sun Pharmaceutical
  • Sumitomo Corporation
  • Enzon Pharmaceuticals
  • Cipla
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Yellow Nail Syndrome Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Yellow Nail Syndrome Treatment Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Yellow Nail Syndrome Treatment Market Dynamics
  1. 2.1 Yellow Nail Syndrome Treatment Industry Trends
  2. 2.2 Yellow Nail Syndrome Treatment Industry Drivers
  3. 2.3 Yellow Nail Syndrome Treatment Industry Opportunities and Challenges
  4. 2.4 Yellow Nail Syndrome Treatment Industry Restraints
3 Yellow Nail Syndrome Treatment Market by Company
  1. 3.1 Global Yellow Nail Syndrome Treatment Company Revenue Ranking in 2025
  2. 3.2 Global Yellow Nail Syndrome Treatment Revenue by Company (2021-2026)
  3. 3.3 Global Yellow Nail Syndrome Treatment Company Ranking (2024-2026)
  4. 3.4 Global Yellow Nail Syndrome Treatment Company Manufacturing Base and Headquarters
  5. 3.5 Global Yellow Nail Syndrome Treatment Company Product Type and Application
  6. 3.6 Global Yellow Nail Syndrome Treatment Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Yellow Nail Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Yellow Nail Syndrome Treatment Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Yellow Nail Syndrome Treatment Market by Type
  1. 4.1 Yellow Nail Syndrome Treatment Type Introduction
  2. 4.1.1 Capsule
  3. 4.1.2 Cream
  4. 4.1.3 Tablet
  5. 4.1.4 Injection
  6. 4.1.5 Others
  7. 4.2 Global Yellow Nail Syndrome Treatment Sales Value by Type
  8. 4.2.1 Global Yellow Nail Syndrome Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Yellow Nail Syndrome Treatment Sales Value by Type (2021-2032)
  10. 4.2.3 Global Yellow Nail Syndrome Treatment Sales Value Share by Type (2021-2032)
5 Yellow Nail Syndrome Treatment Market by Application
  1. 5.1 Yellow Nail Syndrome Treatment Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Yellow Nail Syndrome Treatment Sales Value by Application
  6. 5.2.1 Global Yellow Nail Syndrome Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Yellow Nail Syndrome Treatment Sales Value by Application (2021-2032)
  8. 5.2.3 Global Yellow Nail Syndrome Treatment Sales Value Share by Application (2021-2032)
6 Yellow Nail Syndrome Treatment Regional Value Analysis
  1. 6.1 Global Yellow Nail Syndrome Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Yellow Nail Syndrome Treatment Sales Value by Region (2021-2032)
  3. 6.2.1 Global Yellow Nail Syndrome Treatment Sales Value by Region: 2021-2026
  4. 6.2.2 Global Yellow Nail Syndrome Treatment Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Yellow Nail Syndrome Treatment Sales Value (2021-2032)
  7. 6.3.2 North America Yellow Nail Syndrome Treatment Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Yellow Nail Syndrome Treatment Sales Value (2021-2032)
  10. 6.4.2 Europe Yellow Nail Syndrome Treatment Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Yellow Nail Syndrome Treatment Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Yellow Nail Syndrome Treatment Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Yellow Nail Syndrome Treatment Sales Value (2021-2032)
  16. 6.6.2 South America Yellow Nail Syndrome Treatment Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Yellow Nail Syndrome Treatment Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Yellow Nail Syndrome Treatment Sales Value Share by Country, 2025 VS 2032
7 Yellow Nail Syndrome Treatment Country-level Value Analysis
  1. 7.1 Global Yellow Nail Syndrome Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Yellow Nail Syndrome Treatment Sales Value by Country (2021-2032)
  3. 7.2.1 Global Yellow Nail Syndrome Treatment Sales Value by Country (2021-2026)
  4. 7.2.2 Global Yellow Nail Syndrome Treatment Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Yellow Nail Syndrome Treatment Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Yellow Nail Syndrome Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Yellow Nail Syndrome Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Yellow Nail Syndrome Treatment Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Yellow Nail Syndrome Treatment Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Johnson & Johnson
  14. 8.3.1 Johnson & Johnson Company Information
  15. 8.3.2 Johnson & Johnson Business Overview
  16. 8.3.3 Johnson & Johnson Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Johnson & Johnson Yellow Nail Syndrome Treatment Product Portfolio
  18. 8.3.5 Johnson & Johnson Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Yellow Nail Syndrome Treatment Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck Yellow Nail Syndrome Treatment Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 Merck
  32. 8.6.1 Merck Company Information
  33. 8.6.2 Merck Business Overview
  34. 8.6.3 Merck Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merck Yellow Nail Syndrome Treatment Product Portfolio
  36. 8.6.5 Merck Recent Developments
  37. 8.7 Mylan
  38. 8.7.1 Mylan Company Information
  39. 8.7.2 Mylan Business Overview
  40. 8.7.3 Mylan Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mylan Yellow Nail Syndrome Treatment Product Portfolio
  42. 8.7.5 Mylan Recent Developments
  43. 8.8 Roche
  44. 8.8.1 Roche Company Information
  45. 8.8.2 Roche Business Overview
  46. 8.8.3 Roche Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Roche Yellow Nail Syndrome Treatment Product Portfolio
  48. 8.8.5 Roche Recent Developments
  49. 8.9 Pfizer
  50. 8.9.1 Pfizer Company Information
  51. 8.9.2 Pfizer Business Overview
  52. 8.9.3 Pfizer Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer Yellow Nail Syndrome Treatment Product Portfolio
  54. 8.9.5 Pfizer Recent Developments
  55. 8.10 GlaxoSmithKline
  56. 8.10.1 GlaxoSmithKline Company Information
  57. 8.10.2 GlaxoSmithKline Business Overview
  58. 8.10.3 GlaxoSmithKline Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  59. 8.10.4 GlaxoSmithKline Yellow Nail Syndrome Treatment Product Portfolio
  60. 8.10.5 GlaxoSmithKline Recent Developments
  61. 8.11 Bayer
  62. 8.11.1 Bayer Company Information
  63. 8.11.2 Bayer Business Overview
  64. 8.11.3 Bayer Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Bayer Yellow Nail Syndrome Treatment Product Portfolio
  66. 8.11.5 Bayer Recent Developments
  67. 8.12 AstraZeneca
  68. 8.12.1 AstraZeneca Company Information
  69. 8.12.2 AstraZeneca Business Overview
  70. 8.12.3 AstraZeneca Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  71. 8.12.4 AstraZeneca Yellow Nail Syndrome Treatment Product Portfolio
  72. 8.12.5 AstraZeneca Recent Developments
  73. 8.13 Teva Pharmaceutical
  74. 8.13.1 Teva Pharmaceutical Company Information
  75. 8.13.2 Teva Pharmaceutical Business Overview
  76. 8.13.3 Teva Pharmaceutical Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Teva Pharmaceutical Yellow Nail Syndrome Treatment Product Portfolio
  78. 8.13.5 Teva Pharmaceutical Recent Developments
  79. 8.14 Sun Pharmaceutical
  80. 8.14.1 Sun Pharmaceutical Company Information
  81. 8.14.2 Sun Pharmaceutical Business Overview
  82. 8.14.3 Sun Pharmaceutical Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Sun Pharmaceutical Yellow Nail Syndrome Treatment Product Portfolio
  84. 8.14.5 Sun Pharmaceutical Recent Developments
  85. 8.15 Sumitomo Corporation
  86. 8.15.1 Sumitomo Corporation Company Information
  87. 8.15.2 Sumitomo Corporation Business Overview
  88. 8.15.3 Sumitomo Corporation Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Sumitomo Corporation Yellow Nail Syndrome Treatment Product Portfolio
  90. 8.15.5 Sumitomo Corporation Recent Developments
  91. 8.16 Enzon Pharmaceuticals
  92. 8.16.1 Enzon Pharmaceuticals Company Information
  93. 8.16.2 Enzon Pharmaceuticals Business Overview
  94. 8.16.3 Enzon Pharmaceuticals Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Enzon Pharmaceuticals Yellow Nail Syndrome Treatment Product Portfolio
  96. 8.16.5 Enzon Pharmaceuticals Recent Developments
  97. 8.17 Cipla
  98. 8.17.1 Cipla Company Information
  99. 8.17.2 Cipla Business Overview
  100. 8.17.3 Cipla Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Cipla Yellow Nail Syndrome Treatment Product Portfolio
  102. 8.17.5 Cipla Recent Developments
  103. 8.18 Allergan
  104. 8.18.1 Allergan Company Information
  105. 8.18.2 Allergan Business Overview
  106. 8.18.3 Allergan Yellow Nail Syndrome Treatment Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Allergan Yellow Nail Syndrome Treatment Product Portfolio
  108. 8.18.5 Allergan Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst